Heartflow (HTFL) FCF Margin (2024 - 2025)

Heartflow's (HTFL) quarterly FCF Margin came in at 26.34% in Q4 2025, up 1000.0% year-on-year from 2.39% in Q4 2024, and down 224.81% quarter-over-quarter from 8.11% in Q3 2025.

Heartflow (HTFL) FCF Margin (2024 - 2025) Analysis & Trends

Heartflow's FCF Margin history runs 2 years deep, the most recent figure standing at 26.34% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 1000.0% year-over-year to 26.34% in Q4 2025; TTM through Dec 2025 was 16.92%, a N/A change from a year earlier, with the FY2025 full-year figure at 33.54%, up 2345.0% from the prior year.
  • FCF Margin slipped to 26.34% in Q4 2025 per HTFL's latest filing, from 8.11% in the prior quarter.
  • Across five years, FCF Margin topped out at 8.11% in Q3 2025 and bottomed at 36.34% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn 127.46%
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 2.81%
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn 23.01%
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn 17.24%
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn 23.59%
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn -27.00%
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn 22.17%
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn 79.91%
9 Privia Health 3.10 Bn 2.73 Bn - -8.03%
10 Heartflow 906.97 Mn 730.19 Mn 39.06 Mn -26.34%

Historic Data

Download Data
DateValue
Dec 31, 2025 -26.34%
Sep 30, 2025 -8.11%
Dec 31, 2024 -36.34%
Sep 30, 2024 -34.27%